CAPRICOR THERAPEUTICS, INC. 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Mar 4, 2016
Insider Transaction Report
Form 4
GERSHELL LELAND
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2016-03-02+166,500→ 166,500 totalExercise: $2.19Exp: 2026-03-02→ Common Stock (166,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option award shall vest on April 1, 2017 and the balance shall vest at the rate of 1/36 per month on the first day of each month thereafter, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the Reporting Person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the Reporting Person's service to the Registrant terminates prior to vesting.